Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
U.S. stocks were lower, with the Nasdaq Composite falling around 0.1% on Tuesday.
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) rose sharply during Tuesday's session after the company announced it entered into an agreement to be acquired by Novartis.
Novartis announced a $1.4 billion acquisition of the U.S.-based biotech, strengthening the Swiss drugmaker's pipeline of cardiovascular and kidney treatments.
Novartis will pay $48.00 per share in cash at closing, a 59% premium to Tourmaline's September 8 closing price and 127% above its 60-day volume-weighted average. The deal is expected to close in the fourth quarter of 2025.
Tourmaline Bio shares jumped 58% to $47.65 on Tuesday.
Here are some other big stocks recording gains in today’s session.
Read This Next:
Photo via Shutterstock
Posted In: BABA BHF BILI CIFR DFDV KC NBIS PBF QMMM RIOT RZLV TECK TRML WW WYFI